The following is issued on behalf of the Hospital Authority:

     The Hospital Authority (HA) published the biannual issue of Medication Safety Bulletin (MSB) today (November 24). This issue highlights the updated HA guidelines regarding medication safety in 2023 and new measures to enhance the safe use of allopurinol. It also introduces the potential adverse effects caused by psychiatric drug Clozapine and suggests a future direction for enhancing medication safety.

     In addition, this latest issue shares the New Territories East Cluster's experience in designing a mobile application that functions as a portable reference for Total Parenteral Nutrition drug orders for patients with swallowing difficulties and helps reduce the risks associated with calculations.

     The publication has already been posted on the HA homepage for sharing with healthcare staff. Members of the public are also welcome to browse its content at the following link: www.ha.org.hk/msb. MSB is published every six months, in the last week of May and November. The next issue will be published on May 31, 2024.

Ends/Friday, November 24, 2023
Issued at HKT 16:00

NNNN